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coexpressed in the analyzed cells. In such cases, we contend that stochastic variation in low-copy-number target templates defines the accuracy of sensitive amplification techniques for quantifying relative template levels.
The sensitivity of PCR enables detection of single copies of specific DNA or RNA in a background of micrograms of nonspecific template, but the quantitative accuracy decreases with the amount of input template, becoming highly variable when template copy numbers approach unity 7, 8 . These variations are partly the result of technical and methodological inaccuracy during sample preparation, amplification, and detection, but are highly dependent on the sampling errors arising from the stochastic distribution of low-copy-number template molecules. Assuming that the template molecules are evenly distributed in a solution of known concentration, the probability of a certain number of molecules to be present in an aliquot pipetted from this solution, can be calculated according to the Poisson distribution, as has been done in limitingdilution assays 9 (see Table 1 ).
When a wild-type template is quantified against a reference template (e.g., an internal standard, another DNA/RNA species, or a SNP allele present in the sample), the stochastic variation is even further pronounced. In this case, the ratio of the two templates is dependent on the probability distribution of the copy numbers of each of the respective template molecules, resulting in a multiplication of stochastic effects. In an aliquot expected to contain eight copies each of two separate templates, the 95% confidence interval (CI) estimates of the actual ratio of the two templates ranges from 0.32 to 3.00. At this level, nearly 10-fold differences remain within 95% CI of an unchanged ratio, thus masking even quite dramatic variations, resulting from underlying biological phenomena. When increasing the number of input template molecules, this variability decreases rapidly (Fig. 1) , thus defining the limit for the optimal accuracy at each sensitivity level.
The variation arising from the stochastic distribution of low-copynumber template molecules is a major source of variation, limiting the accuracy of any amplification system optimized for maximal sensitivity. This variation is greatly pronounced when quantification is done against a reference template, but is equally present in kinetic as well as coamplification and competitive PCR systems. Accurate quantification of relative mRNA levels in single cells is possible only for genes expressed at a relatively high level, but for most targets, a greater amount of starting material is required. Using sufficient amounts of starting template (see Fig. 1 ) greatly improves the accuracy of quantitative PCR and is a prerequisite for measuring subtle changes in relative template levels.
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Erratum
On p. 891 of the October 2001 issue, the editorial entitled "Homegrown common sense" contains the statement "These neocolonialists hauled genetic modification up higher on developing countries' agenda (a situation partly exacerbated by corporate agbiotech; for example, Monsanto's ill conceived terminator technology)". In fact, Monsanto never invented the technology, never licensed it, and never worked on it. The patent was filed not by Monsanto, but by USDA scientist Mel Oliver at Texas Tech University, and the patent rights were obtained by the cotton seed company Delta & Pineland (not Monsanto).
